The global celiac disease diagnostics market is projected to reach US$ 626.2 million in 2024 and is expected to grow at a CAGR of 8.5% during the forecast period (2024 to 2034). Advancements in diagnostic technology, such as improved lateral flow assays and ELISA assays, are driving the market’s expansion. Increased public awareness, home-test kits, and new product launches are also contributing to the growth.